Anavex Life Sciences Corp (AVXL)

[JPG77]

Here's what I found interesting in the article:

"Other big pharma companies like Biogen (NASDAQ:BIIB) and Eli Lilly (NYSE:LLY) have been struggling with their Alzheimer's research. Biogen saw a setback with its Alzheimer's drug in the phase 1b trial, known as the PRIME trial. This is because the company saw good results using its 3 mg and 10 mg of its drug, but failed to produce similar results in the 6 mg dose cohort. The drug was shown to reduce amyloid plaques in the brain but had no effect on cognition like Anavex did. Eli Lily saw some good preliminary results, but they tested their trials by comparison. That means they took one of their phase 3 trials and compared it with the other. They looked at patients who took treatment early compared to those that took treatment afterwards. If you want to pick a winner in the Alzheimer's space then Anavex is your best bet based off statistical results to date."